La Jolla Institute For Allergy And Immunology competitive analysis

Latest publications and patents of La Jolla Institute For Allergy And Immunology New

Explore the latest publications and patents granted to La Jolla Institute For Allergy And Immunology, showcasing their recent innovations and technological advancements.

Last updated on: Sep 29, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of La Jolla Institute For Allergy And Immunology

Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease TreatmentRevoked
Aug 16, 2017Antagonistic Hlight-Specific Human Monoclonal AntibodiesRevoked

Explore La Jolla Institute For Allergy And Immunology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment1
Aug 16, 2017Antagonistic Hlight-Specific Human Monoclonal Antibodies1

Latest PTAB cases involving La Jolla Institute For Allergy And Immunology

Discover the latest PTAB cases involving La Jolla Institute For Allergy And Immunology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing La Jolla Institute For Allergy And Immunology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY - 2 - - Non-Active
EUROPEAN OPPOSITIONS30 - - - Highly Aggressive